Over The Counter: How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone

In this episode of HBW Insight's Over the Counter podcast, we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly what consumer health companies need to know about this enormously complex and significant piece of EU legislation.

HBW Over The Counter Podcast

Entering into force on 1 January 2023, but being phased in over a number of years, the Corporate Sustainability Reporting Directive (CSRD) will eventually require an estimated 50,000 companies to disclose information on what they see as the risks and opportunities arising from social and environmental issues, and on the impact of their activities on people and the environment.

And its not just EU companies that are implicated, explains Jasper Crone, who is director of sustainability consultancy CEN-ESG. Around 10,000 international companies with turnover within the EU will be captured, irrespective of where their headquarters are.

For all companies, the CSRD will sharpen focus on factors beyond a company’s operations, for example how human rights are respected across the entire value chain. Here the CSRD will link with other Green Deal legislation, such as the Corporate Sustainability Due Diligence Directive (CSDDD) and the Green Claims Directive, both currently in trilogue negotiations. (Also see "‘Cowboy Companies’ To Be Named, Shamed And Fined Under EU Supply Chain Directive" - HBW Insight, 30 April, 2024.) (Also see "EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine" - HBW Insight, 15 March, 2024.)

For consumer health companies, specific risks will need to be managed and reported, Crone notes. Relevant areas include pollution – for example microplastics, pharmaceuticals in the environment; water use and separately, wastewater pollution; circular economy, which includes packaging waste and social impact, including product affordability, safety, quality. (Also see "Time Running Out To Comply With New EU Sustainability Legislation" - HBW Insight, 19 December, 2023.)

All in all, the CSRD is set to transform the way that all industries operates, Crone warns, and it’s time to get cracking if you haven’t already.

Open Media

Timestamps

2:00 Jasper Crone/CEN-ESG introduction

3:30 Introduction to the CSRD

7:45 What companies are affected by the CSRD

15:00 Specific implications for consumer health companies

21:00 Getting materiality right

25:00 CSRD to do list

32:00 Who’s afraid of targets?

37:00 Who’s responsible for CSRD in companies?

39:00 CSRD and the EU Green Deal

45:00 How will CSRD shape the way companies operate?

Guest Bio

Jasper Crone is a Director at CEN-ESG, a corporate sustainability consultancy which helps businesses maximise their corporate sustainability potential, improving performance and ESG disclosure.

Crone leads on several client teams, covering the implementation of internal controls and sustainability data, setting sustainability and net zero targets and developing programmes for implementation and operationalisation of objectives.

He is experienced in sustainability reporting and the CEN-ESG assists clients with all aspects of sustainability reporting, whether regulatory, investor or customer driven. He brings a range of skills from 20 years of experience in the financial markets, in both the investment banking and investment management industries. He has a BSc in Biology from University of Bristol and is a CFA charterholder.

You can contact Jasper via email: jasper@cen-esg.com

More from Europe

Over The Counter: What To Expect From The 61st AESGP Annual Meeting, With Jurate Švarcaite

 
• By 

HBW Insight speaks to AESGP director general Jurate Švarcaite about what's on the agenda for the upcoming 61st AESGP Annual Meeting, which will take place in Warsaw, Poland, between 2-4 June. Highlights include the role of prevention in self-care, discussions about how regulators will ensure the competitiveness of European industry on the world stage and incoming changes to sustainability legislation.

‘Nothing Unexpected’ In Third Failed Application For OTC Sildenafil In Germany

 
• By 

“Overall, no unexpected/new data or findings” were presented to Germany's Expert Committee for Prescription in the most recent Rx-to-OTC switch application for sildenafil (25mg and 50mg), according to medicines regulator BfArM, resulting in a third rejection in three years.

AESGP Slams ‘Deeply Concerning And Discriminatory’ EU Wastewater Directive

 
• By 

“Protecting the environment is a shared responsibility. It is unfair to expect only two sectors to fund wastewater treatment modernization and operation,” argues AESGP director general Jurate Švarcaite.

New Product Launches Ensured Growth For Stada CHC In 2024

 
• By 

Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.

More from Geography

New Product Launches Ensured Growth For Stada CHC In 2024

 
• By 

Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.

Maxwellia Launches UK TV Campaign For Evana Showing Reality Of Menstruation

 
• By 

Maxwellia's “bold, honest, and completely unfiltered” campaign for Evana menstrual health brand tells the story of a woman dealing with the realities of a heavy period, showing “real blood, real leaks.”

Over The Counter: Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell

 
• By 

HBW Insight catches up with Maxwellia CEO Anna Maxwell to discuss her company's journey so far, and what she sees as the opportunities for Rx-to-OTC switch in UK women's health and beyond.